Spots Global Cancer Trial Database for all, childhood
Every month we try and update this database with for all, childhood cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Childhood Cancer Survivors' Affective Response to Exercise | NCT05763290 | ALL, Childhood Acute Lymphobla... | Affective Respo... | 18 Years - 39 Years | St. Jude Children's Research Hospital | |
| ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT | NCT04785547 | ALL, Childhood Minimal Residua... | Blinatumomab | 6 Months - 21 Years | St. Anna Kinderkrebsforschung | |
| Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy | NCT03889951 | ALL, Childhood | 1 Year - 70 Years | Assiut University | ||
| Childhood Cancer Survivors' Affective Response to Exercise | NCT05763290 | ALL, Childhood Acute Lymphobla... | Affective Respo... | 18 Years - 39 Years | St. Jude Children's Research Hospital | |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma | NCT03817320 | ALL, Childhood Lymphoblastic L... Lymphoblastic L... | Ixazomib Vincristine Dexamethasone Asparaginase Doxorubicin Methotrexate (I... Triple IT (Meth... Leucovorin | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids | NCT04593745 | ALL, Childhood Steroid-Induced... | Intraocular pre... | 1 Month - 20 Years | Rabin Medical Center | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL | NCT06050850 | ALL, Childhood Behavior, Healt... | NOURISH-ALL | 2 Years - 12 Years | University of Kansas Medical Center | |
| A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL | NCT06050850 | ALL, Childhood Behavior, Healt... | NOURISH-ALL | 2 Years - 12 Years | University of Kansas Medical Center | |
| Return to School Adaptation Programme for Children With Cancer | NCT06389357 | Childhood Cance... ALL, Childhood AML, Childhood Lymphoma Solid Tumor, Ch... | training and co... | 8 Years - 17 Years | Gazi University | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| Return to School Adaptation Programme for Children With Cancer | NCT06389357 | Childhood Cance... ALL, Childhood AML, Childhood Lymphoma Solid Tumor, Ch... | training and co... | 8 Years - 17 Years | Gazi University | |
| Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL | NCT02879643 | ALL, Childhood Lymphoblastic L... Lymphoblastic L... | Marqibo | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch | NCT03627208 | Leukemia, Lymph... ALL, Childhood | 2 Years - 40 Years | National Institutes of Health Clinical Center (CC) | ||
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma | NCT03817320 | ALL, Childhood Lymphoblastic L... Lymphoblastic L... | Ixazomib Vincristine Dexamethasone Asparaginase Doxorubicin Methotrexate (I... Triple IT (Meth... Leucovorin | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL | NCT02879643 | ALL, Childhood Lymphoblastic L... Lymphoblastic L... | Marqibo | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
